Rapid cardioversion of new onset atrial fibrillation with ibutilide in the emergency department
Related Experiment Video
Updated: Aug 5, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
D T B Ryan1, F H Cummins, G J Fahy
1Department of Cardiology, South Infirmary/Victoria Hospital, Cork. damienryan03@eircom.net
Insights
Ibutilide effectively converts recent-onset atrial fibrillation and flutter in emergency settings. This antiarrhythmic is a key treatment for patients presenting with these common cardiac arrhythmias.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Atrial fibrillation is a prevalent arrhythmia frequently necessitating emergency department visits.
- Cardioversion is a critical intervention for managing acute atrial fibrillation and flutter.
Observation:
- Ibutilide is an established antiarrhythmic medication.
- Its indication is for cardioversion of atrial fibrillation and flutter.
Findings:
- Ibutilide is indicated for patients with recent-onset atrial fibrillation or flutter (less than 48 hours).
- This treatment aims to restore normal sinus rhythm.
Implications:
- Facilitates timely rhythm control for patients presenting with acute atrial fibrillation/flutter.
- Highlights the role of pharmacologic cardioversion in emergency cardiac care.
Abstract:
People with atrial fibrillation commonly present to the emergency department. Ibutilide is an anti arrhythmic indicated for the cardioversion of atrial fibrillation and flutter where the onset is less than 48 hours.
Related Concept Videos
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias I: Introduction
Dysrhythmias VI: Management of Dysrhythmias
Cardiopulmonary Resuscitation III: AED Use
Cardiopulmonary Resuscitation IV: Pharmacological Management
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

